Award
National Cancer Institute RFA-CA-20-056
Radiation dosimetry for alpha-particle radiopharmaceutical therapy and application to pediatric neuroblastoma
Recipient
Massachusetts General Hospital
Award Amount
$248,997.00
Ceiling
$248,997.00
Awarded
September 03, 2025
Identifier
RFA-CA-20-056
Award for research on alpha-particle radiopharmaceutical therapy and its application to pediatric neuroblastoma, led by Alejandro Bertolet Reina at Massachusetts General Hospital.
Description
This project involves research on alpha-particle radiopharmaceutical therapy, microdosimetry, DNA damage modeling, biodistribution studies, and application to pediatric neuroblastoma. The principal investigator is Alejandro Bertolet Reina from Massachusetts General Hospital. The project is funded by the National Cancer Institute under grant RFA-CA-20-056.